Navigation Links
Compandia Announces Name Change and New Diagnostic Concept

Compandia Announces Name Change and New Diagnostic Concept -- NOTTINGHAM, England, September 15, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services Click to view news release full screen  

Compandia Announces Name Change and New Diagnostic Concept


NOTTINGHAM, England, September 15, 2010 /PRNewswire/ -- Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies. We and our investors have always recognised the significant upside potential in the research work we conduct with collaborators and in the laboratories of our founders, the new name reflects this activity as we start to build our IP portfolio around the signatures and biomarker panels we are developing."

CompanDX also announced the launch of its new "Time to an Event" breast cancer gene panel. CompanDX presents a plenary session today at the British Breast Cancer meeting in Nottingham describing the use of its Risk Distiller bioinformatics tools to deliver the first diagnostic that predicts time to a clinical event. CompanDX scientists have used three public datasets from different clinics to derive a 31 gene signature that predicts time to metastasis following initial surgery and biopsy. The gene signature was subsequently validated on a fourth dataset from yet another clinical centre. Across these patient cohorts the actual versus signature predicted time to metastases has a correlation of 0.86 (p< 0.0001). Furthermore CompanDX for the first time has predicted a "prospective Kaplan Meier curve" which accurately tracks the actual survival curve from the combined data. Here median time to event in the patient population was 3.5 years, this was predicted to be 3.7 years by the CompanDX gene signature with no significant differences between the actual and the CompanDX curves (p = 0.555). Andy Sutton commented "We are very excited about this study, firstly it is real world data from different labs, with no abstraction of outlying patient data. Furthermore it is a 'world first' of a totally new type of diagnostic paradigm with potential to significantly alter clinical management."

CompanDX has applied funding to validate this in the clinic and has secured collaboration with leading clinical centres in London, Nottingham, Cardiff and Holland and also industry support from a world leading diagnostics company in the development of the assay.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 3SBio Announces Partial Conversion of Isotechnika Debenture
2. ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000
3. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
4. Wintherix Announces Potent Small Molecule Wnt Activators for Bone Healing.
5. Southern Research Announces Completion of $20 Million Bond Transaction
6. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
7. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
8. Alere Inc. Announces Offering of $350 Million of Senior Subordinated Notes
9. RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti
10. Elbit Imaging Announces Share Purchase Agreement With Enter Holdings
11. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015  Lannett Company, ... it has completed the acquisition of Kremers Urban ... subsidiary of global biopharmaceuticals company UCB S.A. (Euronext: ... Lannett has acquired KU from UCB for ... certain adjustments, including a customary working capital adjustment, ...
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... , ... According to an article published November 13th on, ... D.C. revolved around the fact that proper dental care, both at-home and in the ... between periodontal disease (more commonly referred to as gum disease) and diabetes. According to ...
(Date:11/27/2015)... NC (PRWEB) , ... November 27, 2015 , ... A ... effective ways to treat it. Surviving Mesothelioma has just posted the findings on ... at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... ... 27, 2015 , ... Intellitec Solutions announced today that they ... Recognized as Microsoft’s official group for end users of Dynamics SL ERP software, ... industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing commitment to ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to announce ... (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored to ... of twelve colleges and universities in the state of California make the cut. CBD ...
Breaking Medicine News(10 mins):